Reckitt Benckiser ploughs £4.5m into Strepsils activity

Strepsils: Reckitt Benckiser ploughs £4.5m into the launch of Sore Throat and Cough
Strepsils: Reckitt Benckiser ploughs £4.5m into the launch of Sore Throat and Cough

Reckitt Benckiser (RB) is kick-starting a £4.5m marketing campaign to support the launch of Strepsils sore throat and cough lozenges.

The campaign, created by EuroRSCG, will feature a TV ad supported by radio, digital, outdoor, PR and point-of-sale activity.

The new product contains two antiseptics and a mild local anaesthetic, Levomenthol, which RB claims relieves dry tickly coughs.

The existing Strepsils portfolio includes Strepsils original, Strepsils, orange and vitamin C, Strepsils sugar free and Strepsils honey and lemon.

Refik Oner, category marketing director, Health and Personal Care, RB UK, said: "With 10 Strepsils lozenges sold every second in the chemist channel we saw an opportunity to develop this trusted brand and the category further by combining efficacious multi-symptom relief in a portable lozenge format.

"We are really excited about the new Strepsils Sore Throat and Cough product which we are confident will be highly incremental for the category as it provides consumers with a unique way to manage unpleasant symptoms during the coming winter months".

Last week RB revamped its 60-year-old Mr Sheen brand to create a "clean modern look" and  introduced a new product to the range.

Start Your Free 30-Day Free Trial

Get the very latest news and insight from Campaign with unrestricted access to campaignlive.com , plus get exclusive discounts to Campaign events.

Become a subscriber

GET YOUR CAMPAIGN DAILY FIX

Don’t miss your daily fix of breaking news, latest work, advice and commentary.

register free